Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) sees a 91.71% increase in stock price, driven by drug pipeline advancements.Hepion Pharmaceuticals, Inc. (OTCQB:HEPA) experiences a 73.91% rise, likely due to its application completion to the OTCQB market and diagnostic test developments.Companies like Mountain Lake Acquisition Corp. (MLACR), and RF Acquisition Corp II Right (RFAIR) show significant jumps, reflecting investor optimism in mergers, acquisitions, and high-growth sectors.The market has recently see ...